Male (2.5th–97.5th) | Female (2.5th–97.5th) | P value* | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14–30 | 31–45 | 46–60 | 61–75 | 76–100 | P value | 14–30 | 31–45 | 46–60 | 61–75 | 76–100 | P value | ||
CD3 + T cell (%) | 51.72–83.08 | 51.60–83.80 | 48.70–84.00 | 41.54–83.20 | 36.28–83.80 | < 0.01 | 56.00–84.20 | 54.40–84.50 | 51.50–83.50 | 46.40–83.30 | 40.27–84.74 | < 0.01 | < 0.01 |
CD3 + CD4 + T cell (%) | 21.70–47.90 | 23.10–51.50 | 22.90–53.30 | 20.30–52.20 | 19.11–50.80 | < 0.01 | 24.70–49.70 | 25.50–51.60 | 24.90–52.90 | 22.30–51.50 | 21.20–51.99 | < 0.01 | < 0.01 |
CD3 + CD8 + T cell (%) | 16.40–42.60 | 14.60–43.33 | 12.60–43.42 | 11.80–45.00 | 10.90–46.81 | < 0.01 | 16.30–41.10 | 15.10–41.30 | 13.10–41.50 | 11.82–43.03 | 11.24–45.02 | < 0.01 | < 0.01 |
CD3 + T cell count (cells/ul) | 714–2300 | 651–2177 | 600–2103 | 525–1997 | 493–1753 | < 0.01 | 688–2155 | 602–1964 | 574–1934 | 556–1974 | 542–1941 | < 0.01 | < 0.01 |
CD3 + CD4 + T cell count (cells/ul) | 328–1225 | 322–1205 | 305–1191 | 272–1113 | 249–923 | < 0.01 | 347–1161 | 301–1089 | 298–1106 | 277–1112 | 266–1074 | < 0.01 | < 0.01 |
CD3 + CD8 + T cell count (cells/ul) | 251–1037 | 204–982 | 169–939 | 153–964 | 138–1026 | < 0.01 | 225–960 | 185–825 | 164–832 | 157–906 | 149–948 | < 0.01 | < 0.01 |